down arrow

HCW Biologics Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US40423R1059
USD
1.98
-0.06 (-2.94%)

Dec 05

NAS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
NanoString Technologies, Inc.
Enzo Biochem, Inc.
Avrobio, Inc.
Elicio Therapeutics, Inc.
Eliem Therapeutics, Inc.
BioXcel Therapeutics, Inc.
YS Biopharma Co. Ltd.
Athira Pharma, Inc.
HCW Biologics Inc.
Vaccinex, Inc.
Syros Pharmaceuticals, Inc.
Why is HCW Biologics Inc. ?
Icon
Unrated Stock - No Analysis Available
stock-recommendationReal-Time Research Report
Verdict Report
Icon
No Data Found
Is HCW Biologics Inc. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
HCW Biologics Inc.
-88.21%
0.02
3673.89%
S&P 500
12.66%
0.61
20.17%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
-72.06%
EBIT Growth (5y)
6.43%
EBIT to Interest (avg)
-14.18
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.50
Sales to Capital Employed (avg)
0.37
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
8.00%
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-1.70
EV to EBIT
-2.12
EV to EBITDA
-2.38
EV to Capital Employed
6.42
EV to Sales
18.97
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-302.10%
ROE (Latest)
Negative BV
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
Bearish
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

7What is working for the Company
OPERATING CASH FLOW(Y)

Highest at USD -12.55 MM

ROCE(HY)

Highest at 0%

NET PROFIT(9M)

Higher at USD -20.85 MM

DEBT-EQUITY RATIO (HY)

Lowest at -11,732.76 %

-25What is not working for the Company
NET SALES(HY)

At USD 0.01 MM has Grown at -99.33%

INTEREST(HY)

At USD 0.48 MM has Grown at 203.47%

RAW MATERIAL COST(Y)

Grown by 62,079.47% (YoY

NET PROFIT(Q)

Lowest at USD -13.69 MM

Here's what is working for HCW Biologics Inc.
Operating Cash Flow
Highest at USD -12.55 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Debt-Equity Ratio
Lowest at -11,732.76 %
in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Here's what is not working for HCW Biologics Inc.
Net Sales
At USD 0.01 MM has Grown at -99.33%
Year on Year (YoY)
MOJO Watch
Near term sales trend is very negative

Net Sales (USD MM)

Interest
At USD 0.48 MM has Grown at 203.47%
over previous Semi-Annual period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Net Profit
At USD -13.69 MM has Fallen at -299.62%
over average net sales of the previous four periods of USD -3.43 MM
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (USD MM)

Net Profit
Lowest at USD -13.69 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is negative

Net Profit (USD MM)

Raw Material Cost
Grown by 62,079.47% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."